Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer

被引:0
|
作者
Wenhao Luo
Lianfang Zheng
Taiping Tai Zhang
机构
[1] Peking Union Medical College Hospital,
来源
Medical Oncology | 2021年 / 38卷
关键词
Apoptosis; Autophagy; Pancreatic cancer; Mechanism; Natural product extracts; Novel strategies;
D O I
暂无
中图分类号
学科分类号
摘要
Pancreatic cancer (PC) is the most lethal malignancy of the gastrointestinal tract. The poor prognosis of patients with PC is primarily due to lack of effective treatments against its progressive and metastatic behavior. Hence, figuring out the mechanisms underlying PC development and putting up with effective targeted therapies are of great significance to improve the prognosis of patients with PC. Apoptosis and autophagy serve to maintain tissue homoeostasis. Escaping from apoptosis or autophagy is one of the features of malignancy. PC is seriously resistant to autophagy and apoptosis, which explains its invasiveness and resistance to conventional treatment. Recently, several biological activities and pharmacological functions found in natural product extracts have been reported to inhibit PC progression. The current review focuses on understanding natural product extracts and their derivatives as one kind of novel treatments through affecting the apoptosis or autophagy in PC.
引用
收藏
相关论文
共 50 条
  • [31] A biopolymer to fight pancreatic cancer
    Lo Giudice, Cristina
    NATURE MATERIALS, 2023, 22 (05) : 528 - 528
  • [32] A biopolymer to fight pancreatic cancer
    Cristina Lo Giudice
    Nature Materials, 2023, 22 : 528 - 528
  • [33] Pimavanserin induces autophagy mediated apoptosis in pancreatic cancer and suppresses pancreatic tumor growth
    Ramachandran, Sharavan
    Srivastava, Sanjay K.
    CANCER RESEARCH, 2020, 80 (16)
  • [34] Kras as a key oncogene and therapeutic target in pancreatic cancer
    Collins, Meredith A.
    di Magliano, Marina Pasca
    FRONTIERS IN PHYSIOLOGY, 2014, 4
  • [35] Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential
    Kwon, Jason J.
    Willy, Jeffrey A.
    Quirin, Kayla A.
    Wek, Ronald C.
    Korc, Murray
    Yin, Xiao-Ming
    Kota, Janaiah
    ONCOTARGET, 2016, 7 (44) : 71635 - 71650
  • [36] Therapeutic developments in pancreatic cancer: current and future perspectives
    Neoptolemos, John P.
    Kleeff, Joerg
    Michl, Patrick
    Costello, Eithne
    Greenhalf, William
    Palmer, Daniel H.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (06) : 332 - 347
  • [37] Therapeutic developments in pancreatic cancer: current and future perspectives
    John P. Neoptolemos
    Jörg Kleeff
    Patrick Michl
    Eithne Costello
    William Greenhalf
    Daniel H. Palmer
    Nature Reviews Gastroenterology & Hepatology, 2018, 15 : 333 - 348
  • [38] Evolution of novel therapeutic options for pancreatic cancer
    Saluja, Ashok K.
    Dudeja, Vikas
    Banerjee, Sulagna
    CURRENT OPINION IN GASTROENTEROLOGY, 2016, 32 (05) : 401 - 407
  • [39] Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer
    Hamada, Shin
    Masamune, Atsushi
    Shimosegawa, Tooru
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [40] A Novel Targeted Therapeutic Agent to Pancreatic Cancer
    Senadhi, Viplove
    Kayarthodi, Shubha
    Fujimura, Yasuo
    Ghanapathy, Bhat
    Buchsbaum, D.
    Rao, Veena
    Reddy, E. Shyam P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S85 - S85